BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 18511076)

  • 1. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
    Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC
    J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study.
    Aydemir O; Deveci A; Taneli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):261-5. PubMed ID: 15694233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants.
    Lee HY; Kim YK
    Neuropsychobiology; 2008; 57(4):194-9. PubMed ID: 18679038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum BDNF levels before treatment predict SSRI response in depression.
    Wolkowitz OM; Wolf J; Shelly W; Rosser R; Burke HM; Lerner GK; Reus VI; Nelson JC; Epel ES; Mellon SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1623-30. PubMed ID: 21749907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different serum BDNF levels in depression: results from BDNF studies in FYR Macedonia and Bulgaria.
    Ristevska-Dimitrovska G; Shishkov R; Gerazova VP; Vujovik V; Stefanovski B; Novotni A; Marinov P; Filov I
    Psychiatr Danub; 2013 Jun; 25(2):123-7. PubMed ID: 23793275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report.
    Martocchia A; Curto M; Scaccianoce S; Comite F; Xenos D; Nasca C; Falaschi GM; Ferracuti S; Girardi P; Nicoletti F; Falaschi P
    Aging Clin Exp Res; 2014 Aug; 26(4):461-4. PubMed ID: 24435333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.
    Gorgulu Y; Caliyurt O
    Brain Res Bull; 2009 Sep; 80(3):158-62. PubMed ID: 19576267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.
    Zhou C; Zhong J; Zou B; Fang L; Chen J; Deng X; Zhang L; Zhao X; Qu Z; Lei Y; Lei T
    PLoS One; 2017; 12(2):e0172270. PubMed ID: 28241064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
    Deuschle M; Gilles M; Scharnholz B; Lederbogen F; Lang UE; Hellweg R
    Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain derived neurotrophic factor (BDNF) levels in depressed women treated with open-label escitalopram.
    Ladea M; Bran M
    Psychiatr Danub; 2013 Jun; 25(2):128-32. PubMed ID: 23793276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
    Grieve SM; Korgaonkar MS; Etkin A; Harris A; Koslow SH; Wisniewski S; Schatzberg AF; Nemeroff CB; Gordon E; Williams LM
    Trials; 2013 Jul; 14():224. PubMed ID: 23866851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
    Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
    Trials; 2011 Jan; 12():4. PubMed ID: 21208417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.
    Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Vanderhasselt MA; Nitsche MA; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1144-51. PubMed ID: 24702987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.
    van der Vinne N; Vollebregt MA; Boutros NN; Fallahpour K; van Putten MJAM; Arns M
    J Affect Disord; 2019 Dec; 259():67-72. PubMed ID: 31437703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters.
    Skibinska M; Kapelski P; Rajewska-Rager A; Pawlak J; Szczepankiewicz A; Narozna B; Twarowska-Hauser J; Dmitrzak-Weglarz M
    Nord J Psychiatry; 2018 Apr; 72(3):191-196. PubMed ID: 29235396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophic factors in depression in response to treatment.
    Buttenschøn HN; Foldager L; Elfving B; Poulsen PH; Uher R; Mors O
    J Affect Disord; 2015 Sep; 183():287-94. PubMed ID: 26047306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
    Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
    Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression.
    Fang Y; Qiu Q; Zhang S; Sun L; Li G; Xiao S; Li X
    J Affect Disord; 2018 Feb; 227():745-751. PubMed ID: 29689690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.